Pavulon
PANCURONIUM_BROMIDE
Organon (India) Limited
It is available as a solution for injection, to be administered by a healthcare provider into the vein.
Store protected from light in single dose container.
Anuria Reduced airway control Lactation
No Disease Found
Neuroleptanalgaesia may decrease neuromuscular activity. Action may be prolonged and/or potentiated by aminoglycoside antibiotics, lithium, diazepam, lidocaine (high dose), quinidine, tetracyclines, propranolol, thiamine (high dose), parenteral magnesium sulphate, MAOIs, quinine, protamine, carbamazepine, donepezil and phenytoin (if pancuronium is given concurrently for <1 wk). Action may be decreased by neostigmine, edrophonium, high-dose or long term corticosteroids, adrenaline (may also potentiate effect), azathioprine, theophylline (high doses), clindamycin, nifedipine, piperacillin, polymixins, verapamil, procainamide. Furosemide may increase or decrease effects. TCAs may increase risk of arrhythmias and hypotension during anaesthesia. Potentiated by volatile anaesthetics (isoflurane and enflurane) and local anaesthetics. Prior administration of suxamethonium can increase the intensity of neuromuscular block. Concomitant use with digoxin may increase risk of serious c
Whether you're looking for a doctor for dealing with your own medical condition, click here to find right physician.
It is any effect of a drug, chemical, or other medicine that is in addition to its intended effect, especially an effect that is harmful or unpleasant.